3-phenoxyazetidine hydrochloride

3-phenoxyazetidine hydrochloride - Names and Identifiers

Name	3-phenoxyazetidine hydrochloride
Synonyms	3-Phenoxyazetidine HCl 3-phenoxyazetidine hydrochloride 3-Phenoxy-azetidinehydrochloride 3-Azetidinyl phenyl ether hydrochloride
CAS	301335-39-7
InChI	InChI=1/C9H11NO.ClH/c1-2-4-8(5-3-1)11-9-6-10-7-9;/h1-5,9-10H,6-7H2;1H

3-phenoxyazetidine hydrochloride - Physico-chemical Properties

Molecular Formula	C9H12ClNO
Molar Mass	185.65068
Boling Point	276.7°C at 760 mmHg
Flash Point	121.2°C
Vapor Presure	0.00364mmHg at 25°C
Storage Condition	under inert gas (nitrogen or Argon) at 2-8°C

3-phenoxyazetidine hydrochloride - Introduction

3-phenoxyazetidine hydrochloride is an organic compound with the chemical formula C11H14ClNO. The following is a description of its nature, use, preparation and safety information:

1. Nature:
-Appearance: 3-phenoxyazetidine hydrochloride is a white or off-white solid powder.
-Melting point: About 144-147 ° C.
-Solubility: It is difficult to dissolve in water, but it is soluble in alcohol and ether.

2. Use:
3-phenoxyazetidine hydrochloride has certain uses in the field of medicine. Some studies have shown that it may have pharmacological activities such as anticancer, antiviral and antifungal. In addition, it is also used as a reagent in organic synthesis.

3. Preparation method:
3-phenoxyazetidine hydrochloride can be synthesized by the following steps:
-First, 3-phenoxyazetidine was synthesized.
-Then, it reacts with hydrochloric acid to produce 3-phenoxyazetidine hydrochloride.

4. Safety Information:
- 3-phenoxyazetidine hydrochloride has not been extensively studied, so relevant safety information is not easy to obtain. When using or handling the compound, it is recommended to use appropriate personal protective equipment, such as gloves and laboratory eye protection equipment.
-Due to the lack of sufficient safety data, necessary risk assessment and laboratory experimental verification are required before use to ensure its correct use.

Last Update：2024-04-09 21:04:16